 |
 |
 |
| 24小時熱門版塊排行榜 |
 |
 |
 |
||
 |
 |
 |
 |
 |
| 1 | 1/1 | 返回列表 |
| 查看: 415 | 回復(fù): 0 | ||
liushuai8608木蟲 (小有名氣)
|
[求助]
醫(yī)學(xué)臨床實(shí)驗(yàn)設(shè)計(jì)
|
|
42. ADIPOA - Clinical Study. 1) Agency &Identifier Agency: University Hospital, Montpellier (First received: March 19, 2012 Last updated: December 3, 2014 Last verified: December 2014) Identifier： 2) Purpose Primary: To study the safety of a single injection of autologous adipose derived mesenchymal stromal cells (ASCs) on patients with moderate or severe osteoarthritis of the knee (OA). Secondary: To study the efficacy of a single injection of autologous adipose derived mesenchymal stromal cells on patients with moderate or severe osteoarthritis of the knee (OA). Condition Intervention Phase Osteoarthritis Biological: Autologous adipose derived stem cells administrated for intra-articular use Phase 1 Arms Assigned Interventions Experimental: Group 1 2 x 10E6 ASC intra-articular injection (5 ml) Biological: Autologous adipose derived stem cells administrated for intra-articular use Each patient will receive one single administration of the cells and will be followed for 3 months. Each patients will be follow-up during one year with routinely examinations for safety issues. The first patient will be followed during 12 weeks before inclusion of the second patient. Experimental: Group 2 10 x 10E6 ASC intra-articular injection (5 ml) Biological: Autologous adipose derived stem cells administrated for intra-articular use Each patient will receive one single administration of the cells and will be followed for 3 months. Each patients will be follow-up during one year with routinely examinations for safety issues. Experimental: Group 3 50 x 10E6 ASC intra-articular injection (5 ml) Biological: Autologous adipose derived stem cells administrated for intra-articular use Each patient will receive one single administration of the cells and will be followed for 3 months. Each patients will be follow-up during one year with routinely examinations for safety issues. 3) Criteria Inclusion Criteria: OA diagnosis should fulfil the criteria of the American College of Rheumatology (ACR) with moderate or severe medial and/ or external femorotibial knee osteoarthritis (OA) (stage 3 or 4) and indication total knee arthroplasty. Exclusion Criteria: Any disease or medication affecting the bone or cartilage metabolism, including corticoids. 4) Outcome Measures Primary Outcome Measures: • Recording of Serious Adverse Events [ Time Frame: during 365 days following injection ] [ Designated as safety issue: Yes ] Adverse events will be described with respect to seriousness, intensity, relationship to treatment, action taken and outcome of the adverse event. Secondary Outcome Measures: • Functional status of the knee [ Time Frame: during 365 days following injection ] [ Designated as safety issue: Yes ] Efficacy will be assessed by measuring: o WOMAC (Western Ontario and McMaster Universities osteoarthritis index), o Short Arthritis assessment Scale (SAS), o range of motion of the target knee joint, o imaging through MRI evaluation, dGEMRIC and T1rho MRI. • Quality of life [ Time Frame: during 365 days following injection ] [ Designated as safety issue: No ] Quality of life will be assessed by measuring: o pain-specific assessment o global patient assessment (visual analog scale, Short-Form 8) o decrease in rescue paracetamol medication. |
回復(fù)此樓» 猜你喜歡
265求調(diào)劑
已經(jīng)有4人回復(fù)
-
085700資源與環(huán)境308求調(diào)劑
已經(jīng)有6人回復(fù)
-
一志愿吉林大學(xué)材料學(xué)碩321求調(diào)劑
已經(jīng)有12人回復(fù)
-
286分人工智能專業(yè)請求調(diào)劑愿意跨考！
已經(jīng)有3人回復(fù)
-
329求調(diào)劑
已經(jīng)有5人回復(fù)
-
申請回稿延期一個月，編輯同意了。但系統(tǒng)上的時間沒變，給編輯又寫郵件了，沒回復(fù)
已經(jīng)有4人回復(fù)
-
材料學(xué)碩318求調(diào)劑
已經(jīng)有5人回復(fù)
-
一志愿中國海洋大學(xué)，生物學(xué)，301分，求調(diào)劑
已經(jīng)有6人回復(fù)
-
081700化工學(xué)碩調(diào)劑
已經(jīng)有3人回復(fù)
-
一志愿蘇州大學(xué)材料求調(diào)劑，總分315（英一）
已經(jīng)有3人回復(fù)
相關(guān)版塊跳轉(zhuǎn)
我要訂閱樓主 liushuai8608 的主題更新
| 1 | 1/1 | 返回列表 |
| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|
|
[論文投稿]
申請回稿延期一個月，編輯同意了。但系統(tǒng)上的時間沒變，給編輯又寫郵件了，沒回復(fù)
 10+3
|
wangf9518 2026-03-17 | 4/200 |
|
|---|---|---|---|---|
|
|
[考研] 材料學(xué)碩318求調(diào)劑 +5 | February_Feb 2026-03-19 | 5/250 |
|
|
|
[考研] 294求調(diào)劑材料與化工專碩 +14 | 陌の森林 2026-03-18 | 14/700 |
|
|
[考研] 085600材料與化工 求調(diào)劑 +14 | enenenhui 2026-03-13 | 15/750 |
|
|
|
[考研] 復(fù)試調(diào)劑 +4 | z1z2z3879 2026-03-14 | 6/300 |
|
|
|
[考研] 材料專碩274一志愿陜西師范大學(xué)求調(diào)劑 +8 | 薛云鵬 2026-03-13 | 8/400 |
|
|
|
[考研] 一志愿西安交通大學(xué)材料工程專業(yè) 282分求調(diào)劑 +5 | 楓橋ZL 2026-03-18 | 7/350 |
|
|
|
[考研] 304求調(diào)劑 +3 | 曼殊2266 2026-03-18 | 3/150 |
|
|
|
[考研] 化學(xué)求調(diào)劑 +3 | 臨澤境llllll 2026-03-17 | 4/200 |
|
|
|
[考研] 328求調(diào)劑，英語六級551，有科研經(jīng)歷 +4 | 生物工程調(diào)劑 2026-03-16 | 12/600 |
|
|
|
[考研] 311求調(diào)劑 +4 | 冬十三 2026-03-18 | 4/200 |
|
|
|
[考研] 材料專業(yè)求調(diào)劑 +5 | hanamiko 2026-03-18 | 5/250 |
|
|
|
[考研] 收復(fù)試調(diào)劑生 +4 | 雨后秋荷 2026-03-18 | 4/200 |
|
|
|
[考研] 考研化學(xué)學(xué)碩調(diào)劑，一志愿985 +4 | 張vvvv 2026-03-15 | 6/300 |
|
|
|
[考研] 308求調(diào)劑 +4 | 是Lupa啊 2026-03-16 | 4/200 |
|
|
|
[考研] 材料與化工專碩調(diào)劑 +5 | heming3743 2026-03-16 | 5/250 |
|
|
|
[考研] 考研調(diào)劑 +3 | 淇ya_~ 2026-03-17 | 5/250 |
|
|
|
[考研] 326求調(diào)劑 +3 | mlpqaz03 2026-03-15 | 3/150 |
|
|
|
[考研] 26考研一志愿中國石油大學(xué)(華東)305分求調(diào)劑 +3 | 嘉年新程 2026-03-15 | 3/150 |
|
|
|
[考研] 328求調(diào)劑 +3 | 5201314Lsy！ 2026-03-13 | 6/300 |
|